[The treatment of intestinal helminthiasis with mebendazole. 294 treated patients].
A Degrémont, Baumgartner Mw
Abstract
A Degrémont, Baumgartner Mw
Abstract
294 patients with slight intestinal helminthic infections have been treated with mebendazole, a broad-spectrum antihelminthic of high effectiveness and remarkably low toxicity. The high cure rates (91-95%) obtained in cases of trichuriasis, ascariasis and ankylostomiasis are in agreement with the results as published by other investigators. For helminthiases, the present patient sample was too limited to permit accurate evaluation. Nevertheless, mebendazole may be considered the drug of choice for treatment of trichuriasis in particular and for intestinal helminthic polyparasitism in general.
OpenAlex reports 5 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
294 patients with slight intestinal helminthic infections have been treated with mebendazole, a broad-spectrum antihelminthic of high effectiveness and remarkably low toxicity. The high cure rates (91-95%) obtained in cases of trichuriasis, ascariasis and ankylostomiasis are in agreement with the results as published by other investigators. For helminthiases, the present patient sample was too limited to permit accurate evaluation. Nevertheless, mebendazole may be considered the drug of choice for treatment of trichuriasis in particular and for intestinal helminthic polyparasitism in general.
Key concepts: Mebendazole, Trichuriasis, Ascariasis, Medicine, Helminthiasis, Helminths, Gastroenterology, Internal medicine